Research Teams Awarded $10.5 Million to Explore AI's Role in Combating Cardiovascular Disease
Two research teams receive significant funding to investigate how artificial intelligence can enhance the detection and treatment of cardiovascular disease, offering potential breakthroughs in early diagnosis and emergency care.
Research teams from Kaiser Permanente Division of Research and the University of Michigan have been awarded a total of $10.5 million to explore the use of artificial intelligence (AI) in improving cardiovascular disease screening and treatment. Funded by the American Heart Association, these projects aim to leverage AI technology to address the leading cause of death in the U.S., with potential implications for early diagnosis and personalized emergency care.
The Kaiser Permanente team, led by David Ouyang, M.D., will focus on using AI to enhance the diagnostic capabilities of echocardiograms, potentially identifying early signs of kidney and liver disease during heart scans. This approach could lead to earlier treatment and reduced complications for cardiovascular patients. Meanwhile, the University of Michigan team, under Cindy Hsu, M.D., Ph.D., M.S., is developing an AI-driven wearable sensor to optimize CPR delivery during cardiac arrest, aiming to improve survival rates through real-time blood flow monitoring.
These initiatives reflect the American Heart Association's commitment to advancing cardiovascular research through innovative technologies. With cardiovascular disease affecting millions globally, the integration of AI into healthcare practices could significantly impact patient outcomes and survival rates.